• Buy 1 Get 1 FREE for immortalized cells| limited time until end of June

  • Boost Your Research with FREE Freezing Medium

Stem Cells

HighQC™ Human IPSC-Derived Cardiac Cells: I-HCm

  • For research use only

Cat No.

ABC-SC0114T

Product Type

Human iPSCs

Cell Type

Cardiac Cell

Species

Human

Growth Conditions

37 ℃, 5% CO2

Source Organ

iPSC

Disease

Normal

Storage

Liquid Nitrogen

Utilize HighQC™ Human IPSC-Derived Cardiac Cells: I-HCm to explore cardiac electrophysiology, drug cardiotoxicity, and regenerative applications.

Product Image

Description

HighQC™ Human iPSC-Derived Cardiac Cells (I-HCm) are differentiated from integration-free human induced pluripotent stem cells (hiPSCs). These cells are not purified through genetic selection, thereby avoiding the risk of genotoxic stress associated with molecular manipulation. Morphologically, I-HCm cells exhibit cardiomyocyte-like features and typically grow as adherent cells forming interconnected cellular networks. After plating at the recommended density, the cells will show spontaneous synchronized beating, and will express typical cardiomyocyte markers, such as the contractile proteins cardiac troponin T (cTNT) and sarcomeric alpha actinin (SaAct). The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.

Product Code

HighQC™ Human IPSC-Derived Cardiac Cells: I-HCm, hIPSC-Cardiac, Human IPSC-Derived Cardiac Cells

Species

Human

Cat.No

ABC-SC0114T

Product Category

Stem Cells

Size/Quantity

1 vial

Cell Type

Cardiac Cell

Growth Mode

Adherent

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

iPSC

Disease

Normal

Storage

Liquid Nitrogen

Product Type

Human iPSCs

Application

  • HighQC™ Human iPSC-Derived Cardiac Cells (I-HCm), also known as iPSC-derived cardiomyocytes (iCM), provide a physiologically relevant platform for evaluating cardiomyocyte-specific responses, such as contractility, electrophysiological activity, and cellular metabolism under controlled experimental conditions. In cardiac disease modeling, I-HCm cells enable the investigation of disease-associated phenotypes and molecular mechanisms relevant to myocardial dysfunction. In addition, they are suitable for assessing potential cardiotoxic effects of compounds by monitoring changes in cell viability, beating behavior, and cardiac marker expression, supporting preclinical safety evaluation and drug discovery research.

Citation

When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
Kussauer S, David R, Lemcke H. hiPSCs Derived Cardiac Cells for Drug and Toxicity Screening and Disease Modeling: What Micro- Electrode-Array Analyses Can Tell Us. Cells. 2019;8(11):1331. Published 2019 Oct 28. doi:10.3390/cells8111331

Inquiring HighQC™ Human IPSC-Derived Cardiac Cells: I-HCm

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button